Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity

被引:140
作者
Wijnhoven, BPL
Siersema, PD
Hop, WCJ
van Dekken, H
Tilanus, HW
机构
[1] Erasmus Univ, Med Ctr, Dept Surg, Rotterdam, Netherlands
[2] Erasmus Univ, Med Ctr, Dept Hepatogastroenterol, Rotterdam, Netherlands
[3] Erasmus Univ, Med Ctr, Dept Epidemiol & Biostat, Rotterdam, Netherlands
[4] Erasmus Univ, Med Ctr, Dept Pathol, Rotterdam, Netherlands
关键词
D O I
10.1046/j.1365-2168.1999.01082.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Adenocarcinomas of the distal third of the oesophagus and the gastric cardia have similar characteristics but different staging criteria are being used. In the present study the question is addressed whether these tumours should be regarded and staged as one clinical entity, Methods: From January 1987 to January 1997, 252 patients with an adenocarcinoma of the oesophagus (n = 111) or gastric cardia (n = 141) underwent transhiatal resection. Pathology, pathological tumour node metastasis (pTNM) stage and survival were analysed retrospectively, and a comparison was made between tumours of the oesophagus and gastric cardia. Results: Barrett's epithelium was diagnosed in 54 per cent of oesophageal adenocarcinomas compared with 13 per cent of adenocarcinomas of the gastric cardia (P < 0.001), Oesophageal carcinomas had a more favourable pT stage, fewer positive locoregional lymph nodes (pN(1-2) 56 versus. 62 per cent; P = 0.3), but more distant metastases accounted for by positive lymph nodes around the coeliac axis (pM(1) 19 versus 4 per cent; P < 0.001). Five-year overall survival (26 versus 27 per cent; P = 0.9) and survival according to tumour stage were no different between the groups. Multivariate analysis showed that the location of the primary tumour was not an independent prognostic factor. Conclusion: Adenocarcinomas of the distal oesophagus and gastric cardia should be regarded as one clinical entity, Uniform staging criteria for both malignancies are recommended.
引用
收藏
页码:529 / 535
页数:7
相关论文
共 41 条
  • [1] [Anonymous], 1992, TNM classification of malignant tumors
  • [2] [Anonymous], 1992, American Joint Committee on Cancer Staging Manual
  • [3] RISING INCIDENCE OF ADENOCARCINOMA OF THE ESOPHAGUS AND GASTRIC CARDIA
    BLOT, WJ
    DEVESA, SS
    KNELLER, RW
    FRAUMENI, JF
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (10): : 1287 - 1289
  • [4] CONTINUING CLIMB IN RATES OF ESOPHAGEAL ADENOCARCINOMA - AN UPDATE
    BLOT, WJ
    DEVESA, SS
    FRAUMENI, JF
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (11): : 1320 - 1320
  • [5] ADENOCARCINOMA OF THE ESOPHAGOGASTRIC JUNCTION AND BARRETTS-ESOPHAGUS
    CAMERON, AJ
    LOMBOY, CT
    PERA, M
    CARPENTER, HA
    [J]. GASTROENTEROLOGY, 1995, 109 (05) : 1541 - 1546
  • [6] Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia
    Chow, WH
    Blot, WJ
    Vaughn, TL
    Risch, HA
    Gammon, MD
    Stanford, JL
    Dubrow, R
    Schoenberg, JB
    Mayne, ST
    Farrow, DC
    Ahsan, H
    West, AB
    Rotterdam, H
    Niwa, S
    Fraumeni, JF
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (02): : 150 - 155
  • [7] CLARK GWB, 1994, ARCH SURG-CHICAGO, V129, P609
  • [8] Is Barrett's esophagus the precursor of most adenocarcinomas of the esophagus and cardia? A biochemical study
    deAlmeida, JC
    Chaves, P
    Pereira, AD
    Altorki, NK
    [J]. ANNALS OF SURGERY, 1997, 226 (06) : 725 - 733
  • [9] DeMeester TR, 1997, SEMIN SURG ONCOL, V13, P217, DOI 10.1002/(SICI)1098-2388(199707/08)13:4<217::AID-SSU2>3.0.CO
  • [10] 2-8